We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CTMX | CytomX Therapeutics Inc | 2.8201 | 1.19 | 73.01% | 31,817,126 |
AKAN | Akanda Corporation | 0.1411 | 0.0481 | 51.72% | 109,648,043 |
PALI | Palisade Bio Inc | 8.89 | 2.86 | 47.43% | 6,342,090 |
CDNA | CareDx Inc | 9.7351 | 1.98 | 25.45% | 380,773 |
RCKY | Rocky Brands Inc | 32.25 | 6.48 | 25.15% | 44,164 |
SRDX | SurModics Inc | 32.00 | 6.31 | 24.56% | 10,869 |
TMDX | TransMedics Group Inc | 116.815 | 22.69 | 24.10% | 908,359 |
BCLI | Brainstorm Cell Therapeutics Inc | 0.4655 | 0.088 | 23.31% | 318,517 |
POWL | Powell Industries Inc | 175.5401 | 32.54 | 22.76% | 200,022 |
TGTX | TG Therapeutics Inc | 16.72 | 3.06 | 22.40% | 4,832,970 |
STI | Solidion Technology Inc | 2.57 | 0.47 | 22.38% | 47,129 |
TORONTO and GLIL YAM, Israel, May 1, 2024 /PRNewswire/ --Â IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March 31, 2024, on Wednesday, May 8, 2024, before the market opens.
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
ANDOVER, Mass., April 30, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2024.
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2024, and updated financial guidance for its fiscal year ending September 30, 2024.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
NWBO | NorthWest Biotherapeutics Inc | 272 | |
FNMA | Fannie Mae | 90 | |
BLEG | Branded Legacy Inc | 148 | |
4 | COOP | Mr Cooper Group Inc | 51 |
5 | NSAV | NSAV Holding Inc | 92 |
6 | AMRN | Amarin Corp Plc | 78 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 57,240.89 | -3,359.39 | -5.54% | 1.12T | 7,878,391,028 |
ETH | Ethereum | 2,891.87 | -118.94 | -3.95% | 346.94B | 3,366,849,355 |
USDT | Tether USD | 0.99896 | -0.00019 | -0.02% | 97.74B | 460,599,273 |
BNB | Binance Coin | 549.57 | -28.01 | -4.85% | 86.53B | 526,711,944 |
SOL | Solana | 123.41 | -3.28 | -2.59% | 54.37B | 1,440,153,391 |
STETH | stETH | 2,881.67 | -127.03 | -4.22% | 28.28B | 14,346,542 |
USDC | USD Coin | 1.00 | 0.0001 | 0.01% | 28.07B | 1,177,859,036 |
XRP | Ripple | 0.4964 | -0.0036 | -0.72% | 27.03B | 372,326,841 |
DOGE | Dogecoin | 0.12379 | -0.00934 | -7.02% | 17.74B | 531,957,147 |
TONCOIN | Wrapped TON Coin | 4.74 | -0.42672 | -8.26% | 16.4B | 128,935,815 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions